Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-03-03 @ 2:07 PM
Study NCT ID:
NCT01889433
Status:
COMPLETED
Last Update Posted:
2018-07-16
First Post:
2013-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
Sponsor:
Biocad
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-26
First Submit QC Date:
None
Study First Post Date:
2013-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-13
Last Update Post Date:
2018-07-16
Last Update Post Date Type:
ACTUAL